Discover 568 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 568
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Oklahoma City OK, Fort Worth TX, San Antonio TX,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase3, Recruiting
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Austin TX, San Antonio TX,
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT06999187
Phase1, Recruiting
Active & ResponsiveNew
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
for
Smoking Cessation
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT07099638
Phase2, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Oklahoma City OK, Houston TX, St Louis MO, Mobile AL,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Oklahoma City OK, Westwood KS, Houston TX, St Louis MO,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
for
Locally Advanced Pancreatic Cancer
Location: Oklahoma City OK, Dallas TX, Omaha NE, Iowa City IA,
Sponsor: RenovoRx
Sex: All
Age: 18+
Code: NCT03257033
Phase3, Recruiting
Active & Responsive
The Artisse⢠Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: Oklahoma City OK, Memphis TN, Englewood CO,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Oklahoma City OK, Springdale AR, Fayetteville AR,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Oklahoma City OK, Houston TX, Bellevue NE, Omaha NE,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Oklahoma City OK, Little Rock AR, Bellevue NE, Omaha NE,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Oklahoma City OK, Lawton OK, Little Rock AR, Omaha NE,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for
Acute Ischemic Stroke
Location: Oklahoma City OK, Shreveport LA, Jacksonville FL,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18 - 70+
Code: NCT05611242
Phase3, Recruiting
Active & Responsive
The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults
for
Cognition,
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 21 - 70+
Code: NCT07209683
Recruiting
Active & Responsive
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
for
Ovarian Cancer
Location: Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 50 - 70+
Code: NCT00539162
Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Oklahoma City OK, Tulsa OK, Fort Worth TX, Dallas TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study